“BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors”. (2024) Bangladesh Journal of Medicine, 35(20), p. 165. doi:10.3329/bjm.v35i20.73432.